Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.

@article{Tabares2006DifferentGS,
  title={Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.},
  author={G. Tabares and Catherine M. Radcliffe and S{\'i}lvia Barrab{\'e}s and Manel Ram{\'i}rez and Rosa N{\'u}ria Aleixandre and Wolfgang Hoesel and Raymond A. Dwek and Pauline M. Rudd and Rosa Peracaula and Rafael de Llorens},
  journal={Glycobiology},
  year={2006},
  volume={16 2},
  pages={132-45}
}
Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH). Glycan processing is normally perturbed in tumors, therefore we investigated whether changes in glycosylation of PSA could be useful diagnostic indicators. Previously we determined that the glycosylation of PSA secreted by the tumor prostate cell line LNCaP differs significantly from that of PSA from seminal plasma… CONTINUE READING
55 Citations
50 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 55 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 50 references

- specific antigen in biological fluids

  • R. N. Knibbs, I. J. Goldstein, R. M. Ratcliffe, N. Shibuya
  • 1991
Highly Influential
4 Excerpts

New serum and urinary markers for prostate cancer detection in the new millennium

  • B. Djavan, Y. K. Fong, M. Remzi, M. Fakhori, M. Marberger
  • Eur. Urol. Suppl.,
  • 2004
Highly Influential
2 Excerpts

Lectin Methods and Protocols

  • J. M. Rhodes, J. D. Milton
  • 1998
Highly Influential
5 Excerpts

Similar Papers

Loading similar papers…